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Materials and Methods 
 
Proteomic analysis using TMT10-plex labeling and liquid chromatography-tandem 
mass spectrometry (LC-MS/MS) 
Proteomics experiments in Fig. S6 were carried out by the Proteomics and Mass 
Spectrometry Core facility at Princeton University. Frozen liver tissues were washed with 
500 μl of 50 mM ammonium bicarbonate buffer and transferred to low binding Eppendorf 
tube. Then 100 μl of lysis buffer (6 M guanidine Hydrochloride, 10 mM TCEP, 40 mM 
CAA, 100 mM Tris pH 8.5, 1x MS-Safe protease inhibitor, 1x Phosphatase inhibitor 
cocktail II) was added and liver tissues were smashed with pellet pestle. Samples were 
vortexed and heated to 95 °C for 10 min with Thermomixer (Eppendorf Co.), sonicated 
for 5 times (15 seconds ON / 10 seconds OFF each time), heated at 95 °C for 5 min and 
then spin down for 1 min at 4000 rpm.  Additional 400 μl of lysis buffer was added again 
and the above tissue smashing with pellet pestle step to spinning down for 1 min at 4000 
rpm step were performed again. Take 100 μl of supernatant and diluted 1:3 with digestion 
buffer (10% Acetonitrile, 25 mM Tris pH8.5) containing LysC (2 μg) and incubated at 37 
°C for 3 hours.  Samples were then further diluted to 1:10 with digestion buffer containing 
Trypsin (10 μg Sequencing Grade, Promega) and incubated overnight at 37 °C.  Add 10% 
TFA to samples to yield final concentration of 1% TFA. Vortex and spin down for 1 min at 
4000 rpm. Supernatant was collected and then desalted on C18 cartridges (Oasis, 
Waters) as per manufacture protocol.  Desalted samples were frozen with liquid nitrogen 
and lyophilized. Dried peptides were reconstituted using 2 ml of 5% Acetonitrile with 0.1% 
formic acid. The absorbance at 205 nm was used to calculate the peptide concentration 
on a Nanodrop (Thermo). An aliquot of 80 μg of each sample was dried in a SpeedVac. 
Each sample was then reconstituted in 80 μl of 0.1 M TEAB pH 8.0 in 20% ACN. 10 μl of 
TMT labeling reagent was then added to each sample and incubated for 1hr at RT on a 
thermomixer. The reaction was quenched by adding hydroxylamine to 0.33%. The 10 
samples were mixed in equimolar amounts (10 μl each) and desalted using C8-stage tips 
(1 x 10 gauge needle disc and 40 μl of 50% AQ3 resin slurry in methanol as in 1).  Dried 
peptide mix was reconstituted in 5% ACN 0.1% formic acid. The 10-plex peptide mix was 
then fractionated using SCX stage-tips (3 x 10 gauge needle discs) as in 2. Six 80 μl 
fractions were collected using: 0.05 M ammonium acetate in 20% acetonitrile; 0.075 M 
ammonium acetate in 20% acetonitrile, 0.125 M ammonium acetate in 20% acetonitrile, 
0.2 M ammonium acetate in 20% acetonitrile, 0.30 M ammonium acetate in 20% 
acetonitrile and 5% ammonium hydroxide in 80% acetonitrile. SCX fractions were dried 
down in SpeedVac and re-dissolved in 20 μl 5% acetonitrile with 0.1% formic acid in 
water. The absorbance at 205 nm was used to calculate the peptide concentration on a 
Nanodrop (Thermo).  Another set of 10 samples were mixed in equimolar amounts (10 μl 
each) and eluted into eight 80 μl fractions using C8-stage tips (1 x 10 gauge needle disc 
and 40 μl of 50% AQ3 resin slurry in methanol as in [1]): 5% buffer B (0.1% formic acid 
in 80% acetonitrile), 7.5% buffer B (0.1% formic acid in 80% acetonitrile), 10% buffer B 
(0.1% formic acid in 80% acetonitrile), 12.5% buffer B (0.1% formic acid in 80% 
acetonitrile), 15% buffer B (0.1% formic acid in 80% acetonitrile), 17.5% buffer B (0.1% 
formic acid in 80% acetonitrile), 20% buffer B (0.1% formic acid in 80% acetonitrile), 50% 
buffer B (0.1% formic acid in 80% acetonitrile).  C8-AQ3 fractions were dried down in 
3 
 
SpeedVac and re-dissolved in 20 μl 5% acetonitrile with 0.1% formic acid in water.  The 
absorbance at 205 nm was used to calculate the peptide concentration on a Nanodrop 
(Thermo).  C8-AQ3 fractions were pooled in the following fashion yielding 4 fractions: #1 
and #5, #2 and #6, #3 and #7, #4 and #8.  This resulted in 6 SCX fractions and 4 C8-AQ3 
fractions with a total of 10 fractions for LC/MS/MS analysis.  
Each of the 10 fractions was injected 2 μl per run using an Easy-nLC 1200 UPLC system.  
Samples were loaded directly onto a 45 cm long 75 μm inner diameter nano capillary 
column packed with 1.9 μm C18-AQ (Dr. Maisch, Germany) mated to metal emitter in-
line with an Fusion Lumos (Thermo Scientific, USA).  Samples were eluted using a 
gradient of 10-20% B (80% acetonitrile with 0.1% FA) in 32 min and 20-40% B in 92 min 
followed by column wash at 100% B for 10 min. The mass spectrometer was operated in 
data dependent mode with the 60,000 resolution MS1 scan (380-1500 m/z), AGC target 
of 4e5 and max injection time of 50 ms.  Peptides above threshold 5e3 and charges 2-7 
were selected for fragmentation with dynamic exclusion after 1 time for 60 s and 10 ppm 
tolerance. MS2 isolation was achieved with 0.8 m/z window by the quadruple with 0.2 m/z 
offset. HCD collision at 33% stepped by 5% was carried out and fragments detected by 
the ion trap in rapid mode with AGC target of 1e4 and max injection time of 50 ms. 10 
SPS precursor were selected within 400-1200 m/z. For MS3 scan, MS1 isolation windows 
of 1.6m/z, MS2 isolation windows 2 and HCD NCE of 55% were selected.  MS3 fragments 
were detected in the Orbitrap at 50,000 resolution in the mass range of 120-500 with AGC 
5e4 and max injection time of 86ms. Total duty cycle was set to 3.0s.   
Raw files were searched with MaxQuant (ver 1.6.0.16)3, using default setting for MS3 
reporter TMT 10-plex data. Carbamidomethylation of cysteine was used as fixed 
modification, oxidation of methionine, and acetylation of protein N-termini were specified 
as dynamic modifications.  Trypsin digestion with maximum of 2 missed cleavages were 
allowed.  Raw files were searched against mouse protein database downloaded from 
UniProt and supplemented with common contaminant proteins.  Raw files were also 
analyzed within the Proteome Discoverer (v 2.1.0.81 Thermo) using Byonic 4 search node 
(Protein Metrics, USA). Deamidation of asparagine, oxidation of methionine, Gln->pyro-
Glu of glutamine and acetylation of protein N-termini were specified in Byonic as variable 
modifications.  
Data from Maxquant and Proteome Discoverer were combined in Scaffold Q+ (version 
Scaffold_4.8.4, Proteome Software Inc., Portland, OR).  Scaffold was used to validate 
MS/MS based peptide and protein identifications. Peptide identifications were accepted 
if they could be established at greater than 80.0% probability by the Scaffold Local FDR 
algorithm. Protein identifications were accepted if they could be established at greater 
than 96.0% probability and contained at least 2 identified peptides.  Protein probabilities 
were assigned by the Protein Prophet algorithm 5. Proteins that contained similar peptides 
and could not be differentiated based on MS/MS analysis alone were grouped to satisfy 
the principles of parsimony.  Scaffold Q+ unnormalized data was exported as a data table 
and further analyzed. Differentially expressed proteins were identified using 20% change 
and P < 0.05. Genes encoding the differentially expressed proteins were input into the 
Database for Annotation, Visualization and Integrated Discovery (DAVID v6.8; 
https://david.ncifcrf.gov/) for Gene Ontology (GO) term enrichment analysis (P < 0.05; at 
least 5 genes in a GO regulated by Meg3). The dot plot for the GO terms as the function 
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of enrichment scores were generated using the R package gplot. Dot sizes represent 
gene ratio, and colors represent P Values.  
In situ RNA detection 
Paraffin sections of human and mouse white adipose tissues were prepared for Meg3 
detection.  In situ RNA detection was performed using RNAscope® 2.5 HD Reagent Kit-
RED (Advanced Cell Diagnostics) and RNAscope® Probe following the manufacturer’s 
instructions.  
Metabolic cage studies 
Metabolic cage studies were performed by the Biomedical and Obesity Research Core of 
UNL. Room temperature for all metabolic studies was maintained at 22°C with a 12 hr 
light/dark cycle. Obese mice treated with gapmeRs (see the section “Mice” above). Mice 
were allowed to acclimate for 1 week in TSE Systems Phenomaster cages. Mice are 
acclimated in acclimation cages that are similar to the experimental cages, one mouse 
per cage. Computer controlled monitoring systems were used to investigate full metabolic 
profile on live mice. The heat production, indirect calorimetry (O2 consumption and CO2 
production), food intake, as well as locomotor activity were measured. All of the 
parameters are measured continuously and simultaneously. Data were collected over the 
course of 3 days after a two-day adaptation.  
Assessment of mitochondrial bioenergetics 
For extracellular acidification rate (ECAR, a proxy to glycolytic flux), cell culture media 
were changed to modified XF assay medium containing 2 mM glutamine. After 1 h 
incubation at 37 ºC without CO2, ECAR were measured using glycolysis stress test kit. 
The data were expressed by normalizing with protein concentration. 
 
 
Supplementary figure legends 
Fig. S1. In situ hybridization of Meg3 using RNAscope® Technology in mouse and 
human white adipose tissues. Representative images of in situ hybridization show 
Meg3 in red. CD31 staining (green) were examined on the adjacent sections. Nuclei was 
stained with DAPI in blue. 
 
Fig. S2. Meg3 knockdown (KD) doesn’t affect glycolysis in HUVECs. Extracellular 
acidification rate (ECAR) was examined in HUVECs transfected with control gapmeRs 
(Ctl) or Meg3 gapmeRs (Meg3 KD), n = 3 independent experiments.  
 
Fig. S3. Mitochondrial (mito.) morphology quantification using a custom-modified 
NIH ImageJ macro. HUVECs were stained with 500 nM mitoTracker green for 30 min 
and treated with 10 μM FCCP for 10 min for live cell imaging (5% CO2 and 37°C with 
humidity). Data were from 20 cells in each condition. Form factor = 




Fig. S4. Metabolic cage studies. Meg3 knockdown (KD) does not affect food intake (A), 
body weight (B), activities (C), heat (D), CO2 production (E), or oxygen consumption (F) 
in obese mice. Mean ± SEM, n = 6 mice per group. 
 
Fig. S5. Meg3 knockdown (KD) reduces the levels of phosphorylated insulin 
receptor β subunit (IRβ) at Tyr1150/1151. C57BL/6 mice were fed a HFD. At Week 5 
on HFD, mice were intravenously injected with control gapmeRs or Meg3 gapmeRs once 
a week and maintained on HFD up to 12 weeks. Total insulin receptor β and the 
phosphorylation at Tyr1150/1151 were examined by western blot in the livers of 
overnight-fasted mice. The tissues were collected at 10 min after insulin injection (0.75 
units/kg). Values are mean ± SEM, n = 4 per group; *, P < 0.05. 
 
Fig. S6. Meg3 knockdown (KD) does not increase systemic inflammation in obese 
mice. (A-F) C57BL/6 mice were fed on a HFD and treated with control gapmeRs or Meg3 
gapmeRs (n = 6 or 7 mice per group). (A) Immunofluorescence staining of Mac2 
(macrophage marker) and perilipin (adipocyte marker) on eWATs sections and Mac2 
quantification. (B) The expression of inflammatory genes was examined in eWATs by 
qPCR. (C) Immunofluorescence staining and quantification of CD68 (macrophage 
marker) on liver sections. (D) The expression of CD68 and F4/80 (macrophage markers) 
and MCP1 (chemokine) was examined in livers by qPCR. (E) The levels of plasma TNFα 
and MCP1 were analyzed by ELISA. (F) Plasma levels of ALT and AST were examined 
in mice treated with control gapmeRs or Meg3 gapmeRs. (G) Meg3 knockdown induces 
type I interferon response in hepatic endothelium (n=6 or 7) and in HUVECs (n=3). For 
all panels, values are mean ± SEM; *, P < 0.05. 
 
Fig. S7. The top ten GO terms that regulated by Meg3. Livers of obese mice injected 
with control gapmeRs or Meg3 gapmeRs (Meg3 KD) were subjected to quantitative 
proteomics (TMT10plex labeling and mass spectrometry) and bioinformatics analysis of 
genes encoding differentially expressed proteins. 
 
Fig. S8. p53 and Meg3 expression in the freshly isolated ECs or in the indicated 
tissues by qPCR or western blot. (A) p53 expression was examined in the freshly 
isolated ECs of livers and skeletal muscles (SM) by qPCR (n = 5 for p53 floxed mice; 
n=14 for p53 iECKO mice). (B) p53 expression was examined in the freshly isolated liver 
ECs by western blot. ECs were pooled from three mice each group. (C) The expression 
of CDKN1A was examined in the freshly isolated liver ECs by qPCR (n = 5, 5, 14, 14 for 
each group of the indicated mice, respectively). N.S., non-significant. (D) p53 expression 
was examined in the livers and skeletal muscles (SM) tissues by qPCR (n = 5 for p53 
floxed mice; n=14 for p53 iECKO mice). (E) Meg3 expression was examined in the freshly 
isolated ECs of livers and skeletal muscles (SM) of p53 iECKO mice or in livers and 
skeletal muscles tissues of p53 iECKO mice (n=7 per group). For all panels, values are 
mean ± SEM; *, P < 0.05. 
 
Fig. S9. Meg3 knockdown (KD) reduces the levels of phosphorylated insulin 
receptor β (IRβ) subunit at Tyr1150/1151. p53 floxed mice were fed a HFD. At Week 5 
on HFD, mice were intravenously injected with control gapmeRs or Meg3 gapmeRs once 
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a week and maintained on HFD up to 12 weeks. Total insulin receptor β and the 
phosphorylation at Tyr1150/1151 were examined by western blot in the livers of 
overnight-fasted mice. The tissues were collected at 10 min after insulin injection (0.75 




Supplementary table legends 
 
Supplementary Table 1: Primers used in the study. “h” is the abbreviation for human; 
“m” is the abbreviation for mouse; “F” stands for forward, and “R” stands for reverse.  
 
Supplementary Table 2: Demographics of human liver specimens.  
 
Supplementary Table 3: Differentially expressed proteins in mouse livers identified by 
quantitative proteomics. Obese mice were injected with control gapmeRs or Meg3 
gapmeRs (10 mg/kg, three injections on three consecutive days). Livers were collected 
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Fig. S1. In situ hybridization of Meg3 using RNAscope® Technology in mouse and human white 
adipose tissues. Representative images of in situ hybridization show Meg3 in red. CD31 staining 
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Fig. S2. Meg3 knockdown (KD) doesn’t affect glycolysis in HUVECs. Extracellular acidification rate 
(ECAR) was examined in HUVECs transfected with control gapmeRs (Ctl) or Meg3 gapmeRs (Meg3 




































Fig. S3. Mitochondrial (mito.) morphology quantification using a custom-modified NIH ImageJ 
macro. HUVECs were stained with 500 nM mitoTracker green for 30 minutes and treated with 10 μM 
FCCP for 10 minutes for live cell imaging (5% CO2 and 37°C with humidity). Data were from 20 cells in 
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Fig. S4. Metabolic cage studies. Meg3 knockdown (KD) does not affect food intake (A), body weight 
(B), activities (C), heat (D), CO2 production (E), or oxygen consumption (F) in obese mice. Mean ± 
SEM, n = 6 mice per group.
Figure S5
Fig. S5. Meg3 knockdown (KD) reduces the levels of phosphorylated insulin receptor β subunit 
(IRβ) at Tyr1150/1151. C57BL/6 mice were fed a HFD. At Week 5 on HFD, mice were intravenously 
injected with control gapmeRs or Meg3 gapmeRs once a week and maintained on HFD up to 12 weeks. 
Total insulin receptor β and the phosphorylation at Tyr1150/1151 were examined by western blot in the 
livers of overnight-fasted mice. The tissues were collected at 10 min after insulin injection (0.75 
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Fig. S6. Meg3 knockdown (KD) does not increase systemic inflammation in obese mice. 
(A-F) C57BL/6 mice were fed on a HFD and treated with control gapmeRs or Meg3 gapmeRs (n = 6 or 
7 mice per group). (A) Immunofluorescence staining of Mac2 (macrophage marker) and perilipin 
(adipocyte marker) on eWATs sections and Mac2 quantification. (B) The expression of inflammatory 
genes was examined in eWATs by qPCR. (C) Immunofluorescence staining and quantification of CD68 
(macrophage marker) on liver sections. (D) The expression of CD68 and F4/80 (macrophage markers) 
and MCP1 (chemokine) was examined in livers by qPCR. (E) The levels of plasma TNFα and MCP1 
were analyzed by ELISA. (F) Plasma levels of ALT and AST were examined in mice treated with control 
gapmeRs or Meg3 gapmeRs. (G) Meg3 knockdown induces type I interferon response in hepatic 
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Figure S7
Fig. S7. The top ten GO terms that regulated by Meg3. Livers of obese mice injected with control 
gapmeRs or Meg3 gapmeRs (Meg3 KD) were subjected to quantitative proteomics (TMT10plex labeling 














































Fig. S8. p53 and Meg3 expression in the freshly isolated ECs or in the indicated tissues by qPCR or 
western blot. (A) p53 expression was examined in the freshly isolated ECs of livers and skeletal muscles 
(SM) by qPCR (n = 5 for p53 floxed mice; n=14 for p53 iECKO mice). (B) p53 expression was examined in 
the freshly isolated liver ECs by western blot. ECs were pooled from three mice each group. (C) The 
expression of CDKN1A was examined in the freshly isolated liver ECs by qPCR (n = 5, 5, 14, 14 for each 
group of the indicated mice, respectively). N.S., non-significant. (D) p53 expression was examined in the 
livers and skeletal muscles (SM) tissues by qPCR (n = 5 for p53 floxed mice; n=14 for p53 iECKO mice). (E) 
Meg3 expression was examined in the freshly isolated ECs of livers and skeletal muscles (SM) of p53 
iECKO mice or in livers and skeletal muscles tissues of p53 iECKO mice (n=7 per group). For all panels, 
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Fig. S9. Meg3 knockdown (KD) reduces the levels of phosphorylated insulin receptor β subunit 
(IRβ) at Tyr1150/1151. p53 floxed mice were fed a HFD. At Week 5 on HFD, mice were intravenously 
injected with control gapmeRs or Meg3 gapmeRs once a week and maintained on HFD up to 12 weeks. 
Total insulin receptor β and the phosphorylation at Tyr1150/1151 were examined by western blot in the 
livers of overnight-fasted mice. The tissues were collected at 10 min after insulin injection (0.75 


















Supplementary Table S1 
Gene Sequences (5’-3’) 
mMeg3 F TCACCTCCAATTTCCCCTCC 
mMeg3 R GCAAGCCAAGCCTTAAACCT 
mCDKN1A F CCTGGTGATGTCCGACCTG 
mCDKN1A R CCATGAGCGCATCGCAATC 
mCDKN2A F CGCAGGTTCTTGGTCACTGT 
mCDKN2A R TGTTCACGAAAGCCAGAGCG 
mGADD45A F CCGAAAGGATGGACACGGTG 
mGADD45A R TTATCGGGGTCTACGTTGAGC 
mRRAD F GTCAGAGGAGGGCGTTTACAAA 
mRRAD R TCCACAGTGATAGAACGGTCA 
hMeg3 F GGGCATTAAGCCCTGACCTT 
hMeg3 R CCTTGGGGAGGGAAACACTC 
hCDKN1A F CTGGAGACTCTCAGGGTCGAAA 
hCDKN1A R GATTAGGGCTTCCTCTTGGAGAA 
hCDKN2A F GGGTTTTCGTGGTTCACATCC 
hCDKN2A R CTAGACGCTGGCTCCTCAGTA 
hGAPDH F ATGGGGAAGGTGAAGGTCG 
hGAPDH R GGGGTCATTGATGGCAACAATA 
mTNFα F CCCTCACACTCAGATCATCTTCT 
mTNFα R GCTACGACGTGGGCTACAG 
mICAM1 F GTGATGCTCAGGTATCCATCCA 
mICAM1 R CACAGTTCTCAAAGCACAGCG 
mCD68 F TGTCTGATCTTGCTAGGACCG 
mCD68 R GAGAGTAACGGCCTTTTTGTGA 
mF4/80 F CCCCAGTGTCCTTACAGAGTG 
mF4/80 R GTGCCCAGAGTGGATGTCT 
mMCP1 F TTAAAAACCTGGATCGGAACCAA 
mMCP1 R GCATTAGCTTCAGATTTACGGGT 
mIFN-β F GCACTGGGTGGAATGAGACT 
mIFN-β R AGTGGAGAGCAGTTGAGGACA 
mIRGM F CATAGGGAACTTCTGCCGGA 
mIRGM R AGTTGGTTCCTTCGAATGCCT 
mp53 F CCATGGCCCCTGTCATCTTT 
mp53 R TGAGGGGAGGAGAGTACGTG 
mHprt F TCAGTCAACGGGGGACATAAA 
mHprt R GGGGCTGTACTGCTTAACCAG 
 
Supplementary Table S2. Biometrics 
of human subjects 
Group n M / F Age (year) 
Normal 7 5 / 2 42 ± 16 
NAFLD 6 2 / 4 48 ± 20 
NASH 7 0 / 7 55 ± 10 
Supplementary Table S3
Identified Proteins Gene Name MW Expression
1 Major urinary protein 1 Mup1 21 kDa Down
2 Major urinary protein 10 Mup10 21 kDa Down
3 FERM, RhoGEF and pleckstrin domain-containing protein 1 Farp1 119 kDa Down
4 NADPH oxidase organizer 1 Noxo1 39 kDa Down
5 E3 ubiquitin-protein ligase NEDD4 Nedd4 103 kDa Down
6 Aldose reductase-related protein 2 Akr1b8 36 kDa Down
7 Plexin-B2 Plxnb2 206 kDa Down
8 A-kinase anchor protein 13 Akap13 304 kDa Down
9 Lipoma-preferred partner homolog Lpp 66 kDa Down
10 CMRF35-like molecule 9 Cd300lg 37 kDa Down
11 Beta-1-syntrophin Sntb1 58 kDa Down
12 CD166 antigen Alcam 65 kDa Down
13 Membrane associated guanylate kinase, WW and PDZ domain containing 3 Magi3 162 kDa Down
14 Propionyl-CoA carboxylase alpha chain, mitochondrial Pcca 80 kDa Down
15 Protein kinase C and casein kinase II substrate protein 3 Pacsin3 49 kDa Down
16 Betaine--homocysteine S-methyltransferase 1 Bhmt 45 kDa Down
17 Gephyrin OS=Mus musculus Gphn 84 kDa Down
18 Cysteine-rich protein 2 Crip2 23 kDa Down
19 Succinate--hydroxymethylglutarate CoA-transferase Sugct 48 kDa Down
20 CASP8-associated protein 2 Casp8ap2 219 kDa Down
21 Myb-binding protein 1A Mybbp1a 152 kDa Down
22 Non-histone chromosomal protein HMG-14 Hmgn1 9 kDa Down
23 Methylcytosine dioxygenase TET3 Tet3 180 kDa Down
24 Sulfotransferase Sult1a1 30 kDa Down
25 Mitochondrial peptide methionine sulfoxide reductase Msra 26 kDa Down
26 Alpha-defensin 20 Defa20 11 kDa Down
27 Diphosphomevalonate decarboxylase Mvd 44 kDa Down
28 Propionyl-CoA carboxylase beta chain, mitochondrial Pccb 58 kDa Down
29 Carnitine O-palmitoyltransferase 2, mitochondrial Cpt2 74 kDa Down
30 Tetratricopeptide repeat protein 36 Ttc36 20 kDa Down
31 Partner of Y14 and mago Pym1 23 kDa Down
32 Citrate lyase subunit beta-like protein, mitochondrial Clybl 38 kDa Down
33 Alpha-tocopherol transfer protein Ttpa 32 kDa Down
34 Oxysterol-binding protein-related protein 2 Osbpl2 55 kDa Down
35 Talin-2 Tln2 272 kDa Down
36 Mitochondrial antiviral-signaling protein Mavs 53 kDa Down
37 Epidermal growth factor receptor substrate 15 Eps15 98 kDa Down
38 Histone H1.0 H1f0 21 kDa Down
39 EH domain-containing protein 3 Ehd3 61 kDa Down
40 N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 Ddah1 31 kDa Down
41 Thyroid hormone-inducible hepatic protein Thrsp 17 kDa Down
42 Cytosolic non-specific dipeptidase Cndp2 53 kDa Down
43 Alpha-actinin-4 Actn4 105 kDa Down
44 Intracellular hyaluronan-binding protein 4 Habp4 46 kDa Down
1 Nidogen-1 Nid1 137 kDa up
2 Polymerase I and transcript release factor Ptrf 44 kDa up
3 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 Ndufa12 18 kDa up
4 Eukaryotic translation initiation factor 3 subunit C Eif3c 106 kDa up
5 Carbonic anhydrase 3 Ca3 29 kDa up
6 Apolipoprotein E Apoe 36 kDa up
7 NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial Ndufs2 50 kDa up
8 L-serine dehydratase/L-threonine deaminase Sds 35 kDa up
9 Flavin reductase (NADPH) Blvrb 22 kDa up
10 Transcriptional activator protein Pur-alpha Pura 35 kDa up
11 Hydroxyproline dehydrogenase Prodh2 51 kDa up
12 Alanyl-tRNA editing protein Aarsd1 Aarsd1 45 kDa up
13 Isobutyryl-CoA dehydrogenase, mitochondrial Acad8 45 kDa up
14 Glutathione S-transferase omega-1 Gsto1 27 kDa up
15 Alanine aminotransferase 2 Gpt2 58 kDa up
16 Methyltransferase-like protein 7B Mettl7b 28 kDa up
17 NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial Ndufs8 24 kDa up
18 Fructose-1,6-bisphosphatase 1 Fbp1 37 kDa up
19 Aldehyde dehydrogenase X, mitochondrial Aldh1b1 58 kDa up
20 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 Ndufb10 21 kDa up
21 Metastasis-associated protein MTA2 Mta2 75 kDa up
22 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial Ndufa9 43 kDa up
23 Capping protein (Actin filament), gelsolin-like Capg 39 kDa up
24 Laminin subunit beta-2 Lamb2 197 kDa up
25 Sulfurtransferase Mpst 33 kDa up
26 Dipeptidyl peptidase 2 Dpp7 56 kDa up
27 Gamma-butyrobetaine dioxygenase Bbox1 45 kDa up
28 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial Ndufb11 17 kDa up
29 Alcohol dehydrogenase 1 Adh1 40 kDa up
30 UDP-glucuronosyltransferase Ugt2b34 61 kDa up
31 Erythrocyte band 7 integral membrane protein Stom 31 kDa up
32 Myristoylated alanine-rich C-kinase substrate Marcks 30 kDa up
33 Telomerase protein component 1 Tep1 291 kDa up
34 3-ketoacyl-CoA thiolase B, peroxisomal Acaa1b 44 kDa up
35 Integrin beta-1 Itgb1 88 kDa up
36 RAB1A, member RAS oncogene family Rab1a 22 kDa up
37 High mobility group protein B2 Hmgb2 24 kDa up
38 Heme oxygenase 2 (Fragment) Hmox2 26 kDa up
39 Cathepsin F Ctsf 52 kDa up
40 Cytochrome P450 2E1 Cyp2e1 57 kDa up
41 MCG10343, isoform CRA_b Slc25a3 40 kDa up
42 Ras-related protein Rab-1B Rab1b 22 kDa up
43 Deoxyuridine triphosphatase Dut 21 kDa up
44 Collagen type IV alpha-3-binding protein Col4a3bp 71 kDa up
45 Indolethylamine N-methyltransferase Inmt 29 kDa up
46 Alcohol dehydrogenase 4 Adh4 40 kDa up
47 Chloride intracellular channel protein 4 Clic4 29 kDa up
48 Histone H1.5 Hist1h1b 23 kDa up
49 Bile acyl-CoA synthetase Slc27a5 76 kDa up
50 Collagen alpha-1(XIV) chain Col14a1 193 kDa up
51 Histone H1.3 Hist1h1d 22 kDa up
52 Ferritin Ftl1 21 kDa up
53 Carboxylesterase 1E Ces1e 62 kDa up
54 Glutathione S-transferase A4 Gsta4 26 kDa up
55 Ferritin heavy chain Fth1 21 kDa up
56 Coronin-1A Coro1a 51 kDa up
57 Ear6 protein Ear6 17 kDa up
58 Heat shock protein beta-1 Hspb1 23 kDa up
59 Adenylate kinase 2, mitochondrial (Fragment) Ak2 7 kDa up
60 Epoxide hydrolase Ephx1 51 kDa up
